MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
In the last 30 days, Stryker (NYSE:SYK) again claimed the top seat for most internet chatter, although the news well wasn’t nearly as full.
Med-tech titan Medtronic (NYSE:MDT) took a strong 2nd as the company spent part of the month tangled in St. Jude Medical (NYSE:STJ) recall fiasco. Medtronic also issued a clutch of news regarding stents, neuromodulation, pumps and more.
Covidien (NYSE:COV) commanded a good bit of attention last month, riding high on a merger-spree and its latest earnings release. St. Jude came in 4th, with its unusual management of the fallout from its high-profile Riata defibrillator lead recall dominating the news for nearly a week straight.
Topping off the list this month, Boston Scientific (NYSE:BSX) made headlines with regulatory wins, heart device warnings and the spotlight on soon-to-be subsidiary Cameron Health’s lead-free implantable ICD.
Read on for more news and links to the stories that everyone was talking about this month.
Stryker
- Device makers lack green initiative, report says – April 5
- NeuroLogica, Stryker in surgical CT scanner pact – April 13
- More warnings on metal-on-metal hip implants in U.K, New Zealand – April 13
- Stryker ticks up on beat & meet Q1 – April 18
- Stryker’s New York plant goes up for sale – April 18
Medtronic
- Medtronic’s Resolute stent meets Abbott’s Xience in “real world” patients – April 3
- Medtronic confirms Hauser’s findings – April 9
- CRM wins for Medtronic, Boston Scientific – April 10
- Heart doc on St. Jude, MDT Riata fight: “I can’t recall seeing a more contentious” dispute – April 10
- Medtronic expands in Ireland, Florida – April 11
- Medtronic lands Canadian win for epilepsy therapy with brain stim – April 12
- Judge stays Biotronik suit against Medtronic so Medtronic can finish suing ex-sales rep and Biotronik – April 12
- Medtronic launches drug-eluting balloon study – April 13
- Medtronic, J&J, Abbott make the list of 100 best corporate citizens for 2012 – April 15
- Medtronic wins pain pump case on preemption – April 19
- Medtronic expands in Montreal – April 25
- Fake Medtronic merch lands California woman in prison – April 30
Covidien
- Covidien notches a win in long-running trocar patent battle with Applied Medical – April 4
- Oridion shares spike 70% on Covidien merger news – April 5
- Covidien beats The Street, maintains guidance – April 27
- Covidien nabs a 3rd Israeli device maker – April 30
St. Jude Medical
- St. Jude slumps on another lead recall – April 4
- St. Jude demands retraction of Hauser Riata report – April 6
- St. Jude, on the attack, calls out Medtronic for “whisper campaign” – April 9
- HRS preview: St. Jude, Boston Scientific in the spotlight – April 9
- FDA looks to strengthen device surveillance post-Riata – April 10
- Hearth Rhythm Society won’t retract Riata piece – April 10
- St. Jude, firing back, posts 377 Medtronic Quattro lead deaths – April 10
- Heart doc on St. Jude, MDT Riata fight: “I can’t recall seeing a more contentious” dispute – April 10
- St. Jude Medical gets tangled in its own rope over Riata – April 13
- St. Jude touts CE Mark for next-gen high-energy ICD – April 17
- St. Jude slumps along with its CRM sales – April 18
- St. Jude softens rhetoric against Riata researcher Hauser – April 18
- Abbott, St. Jude Medical re-up ‘cardiovascular alliance’ – April 23
Boston Scientific
- Boston Scientific launches Pluromed’s BackStop kidney stone treatment – April 2
- Boston Scientific whistleblower sales rep gets the OK to pursue wrongful termination claim – April 4
- HRS preview: St. Jude, Boston Scientific in the spotlight – April 9
- CRM wins for Medtronic, Boston Scientific – April 10
- J&J appeals Boston Scientific’s $40M stent patent win – April 17
- Boston Scientific blows Wall Street away, even as CRM sales lose 10% – April 19
- Boston Scientific warns on ICD electrical malfunction following patient death – April 23
- Boston Scientific touts CE Mark for next-gen dilation catheters – April 24
- Analysts cautious on Boston Scientific’s $1.3B lead-free ICD ahead of FDA panel – April 24
- Stents: Boston Scientific launches new Promus Element Plus in Canada – April 25
- Boston Scientific wins PMA for Epic stent – April 25
- BSX ticks up on positive panel vote for Cameron S-ICD – April 27
